Central Hypothyroidism and Its Replacement Have a Significant Influence on Cardiovascular Risk Factors in Adult Hypopituitary Patients
The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
Context: Thyroid dysfunction may have detrimental effects on patient outcomes. Few studies have assessed this issue in patients with secondary hypothyroidism. Objective: Our objective was to test the hypothesis that thyroid hormone status has an impact on cardiovascular risk factors in adult patients with hypopituitarism. Design and Setting: This was a retrospective observational study (1993–2012) at a tertiary referral university hospital. Patients: All GH-deficient patients starting GH replacement (1993–2009) with measured free T4 (fT4) (n = 208). Baseline fT4 defined patients as TSH-sufficient and TSH-deficient (further divided into tertiles according to baseline fT4; first tertile had lowest fT4). Main Outcome Measures: Anthropometric (body mass index [BMI], waist circumference, total fat (fat mass) and lean body mass [LBM]) and biochemical (lipids and fasting plasma glucose) data were collected at baseline and a median 4.1 years after commencement of GH. Results: At baseline, fT4 was negatively associated with BMI and waist circumference, but positively with high-density lipoprotein, independent of age, gender, and IGF-I (SD score). Only first-tertile TSH-deficient patients had higher BMI (P = .02), fat mass (P = .03), total cholesterol (P = .05), triglycerides (P < .01), and waist circumference (P = .01), and lower high-density lipoprotein cholesterol (P = .03) as compared with TSH-sufficient patients. At follow-up, IGF-I, LBM, and plasma glucose had increased in all subgroups (P < .01). The change in fT4 (ΔfT4) (follow-up − baseline) was negatively correlated to ΔBMI, ΔLBM, Δtotal cholesterol, and Δlow-density lipoprotein cholesterol (all P < .05, adjusted for ΔIGF-I and ΔGH and hydrocortisone dose). The negative correlation to Δtotal cholesterol and Δlow-density lipoprotein cholesterol persisted only in first-tertile TSH-deficient patients. Conclusion: This single-center study over a 20-year period has strengthened the importance of improved awareness of thyroid status and optimal thyroid replacement of hypopituitary patients to reduce cardiovascular risks in hypopituitary patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, a recent publication reported that increased risk of vertebral fracture in hypopituitary patients receiving higher daily doses of L-T4 correlated with higher fT4 levels (131).”
From Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline (2016) · cites this paper as [131]
In the citing paper
“Other pituitary hormone deficits and/or their treatment also affect BMD and the risk of fracture in central hypogonadism (131,159,160).”
From Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline (2016) · cites this paper as [131]
In the citing paper
“higher fat mass, worse lipid profile (total cholesterol, LDL-cholesterol, HDL-cholesterol, triglycerides) (107)”
From L-T4 therapy in the presence of pharmacological interferents (2020) · cites this paper as [107]
In the citing paper
“Accordingly, patients treated with thyroxine replacement will generally need to increase the dose after GH therapy has started (Filipsson Nyström et al., 2011;Jørgensen et al., 1992;Klose et al., 2013).”
From The hypothalamus-pituitary-thyroid (HPT)-axis and its role in physiology and pathophysiology of other hypothalamus-pituitary functions (2021) · cites this paper as Klose et al., 2013
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Laboratory Support for the Diagnosis and Monitoring of Thyroid Disease
(2003) · Thyroid · doi:10.1089/105072503321086962 · Cited by 1,212
Self-citationKnudsen, N., Laurberg, P., Rasmussen, L. B., Bülow, I., Perrild, H., Ovesen, L., & Jørgensen, T. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2225 · Cited by 753
Mortality in Patients with Pituitary Disease
Sherlock, M., Ayuk, J., Tomlinson, J. W., Toogood, A. A., Aragon-Alonso, A., Sheppard, M. C., Bates, A. S., & Stewart, P. M. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0033 · Cited by 392
Central Hypothyroidism: Pathogenic, Diagnostic, and Therapeutic Challenges
Persani, L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1616 · Cited by 295
JøRGENSEN, J. O. L., PEDERSEN, S. A., LAURBERG, P., WEEKE, J., SKAKKEBÆK, N. E., & CHRISTIANSEN, J. S. (1989) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-69-6-1127 · Cited by 192
Mortality and morbidity in adult craniopharyngioma
Erfurth, E. M., Holmer, H., & Fjalldal, S. B. (2012) · Pituitary · doi:10.1007/s11102-012-0428-2 · Cited by 163
Alexopoulou, O., Beguin, C., De Nayer, P., & Maiter, D. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1500001 · Cited by 135
Ferretti, E., Persani, L., Jaffrain-Rea, M.-L., Giambona, S., Tamburrano, G., & Beck-Peccoz, P. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.3.5553 · Cited by 134
Cited by
Jonklaas, J., Bianco, A. C., Bauer, A. J., Burman, K. D., Cappola, A. R., Celi, F. S., Cooper, D. S., Kim, B. W., Peeters, R. P., Rosenthal, M. S., et al. (2014) · Thyroid® · doi:10.1089/thy.2014.0028 · Cited by 1,928
“A retrospective study also suggested that higher FT4 values within the normal range had most benefit on lipid parameters and body composition (399).”
Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline
Fleseriu, M., Hashim, I. A., Karavitaki, N., Melmed, S., Murad, M. H., Salvatori, R., & Samuels, M. H. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2118 · Cited by 945
A Consensus on the Diagnosis and Treatment of Acromegaly Comorbidities: An Update
Giustina, A., Barkan, A., Beckers, A., Biermasz, N., Biller, B. M. K., Boguszewski, C., Bolanowski, M., Bonert, V., Bronstein, M. D., Casanueva, F. F., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz096 · Cited by 371
Higham, C. E., Johannsson, G., & Shalet, S. M. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30053-8 · Cited by 267
Treatment with thyroid hormone
Biondi, B., & Wartofsky, L. (2014) · Endocrine Reviews · doi:10.1210/er.2013-1083 · Cited by 259
Metadata
- Authors
- Klose, M., Marina, D., Hartoft-Nielsen, M.-L., Klefter, O., Gavan, V., Hilsted, L., Rasmussen, Å. K., & Feldt-Rasmussen, U.
- Affiliations
- Copenhagen University Hospital (DK)
- Departments of Medical Endocrinology (M.K., D.M., M.-L.H.-N., O.K., V.G., Å.K.R., U.F.-R.), DK-2100 Copenhagen, Denmark
- Corresponding author
- Klose, M.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2013-09-01
- Volume
- 98
- Issue
- 9
- Pages
- 3802-3810
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2027769018
- Semantic Scholar
- 5808a8eaad681930b187fd4a740973b32ef481b3
- Cited by
- 53
- References
- 34
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 2 · 2023: 3 · 2022: 6 · 2021: 7 · 2020: 2 · 2019: 6 · 2018: 5 · 2017: 2 · 2016: 4 · 2015: 3 · 2014: 7 · 2013: 1
- FWCI
- 3.93
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Funders
- Gentofte Hospital
- Novo Nordisk
- Rigshospitalet
- Region Hovedstaden
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Keywords
- central hypothyroidism, hypopituitarism, growth hormone deficiency, thyroid hormone replacement, free thyroxine, cardiovascular risk factors, body mass index, waist circumference, fat mass, lean body mass, lipids, total cholesterol, LDL cholesterol, HDL cholesterol, fasting blood glucose, insulin-like growth factor I
- MeSH terms
- Adult, Aged, Blood Glucose, Body Composition, Cardiovascular Diseases, Female, Humans, Hypopituitarism, Hypothyroidism, Male, Middle Aged, Risk Factors, Thyroxine, Triglycerides, Body Mass Index, Human Growth Hormone, Hormone Replacement Therapy, Waist Circumference
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Central Hypothyroidism and Its Replacement Have a Significant Influence on Cardiovascular Risk Factors in Adult Hypopituitary Patients. https://app.cochat.ai/papers/10.1210/jc.2013-1610
- The paper
- Klose, M., Marina, D., Hartoft-Nielsen, M.-L., Klefter, O., Gavan, V., Hilsted, L., Rasmussen, Å. K., & Feldt-Rasmussen, U. (2013). Central Hypothyroidism and Its Replacement Have a Significant Influence on Cardiovascular Risk Factors in Adult Hypopituitary Patients. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2013-1610
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.